Editorial: Bile acid profiles in intrahepatic cholestasis of pregnancy: Is this the solution to the enigma of intrahepatic cholestasis of pregnancy

Emmanouil Sinakos, Keith Lindor

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Intrahepatic cholestasis of pregnancy (ICP) is a rare pregnancy-related liver disease characterized by pruritus, abnormal liver function tests, and an increased risk of fetal complications. An increase in the levels of bile acids is considered to be the diagnostic hallmark of the disease. Ursodeoxycholic acid (UDCA) is currently the most effective therapy. Tribe et al. (this issue) hypothesized that measuring the longitudinal profiles of individual bile acids would provide further insight into the mechanisms of disease. They used a novel chromatography method, which allowed the simultaneous measurement of 15 serum bile acids between 16 weeks of pregnancy and 4 weeks post-partum. ICP was associated with a predominant rise in cholic acid conjugated with taurine and glycine from 24 weeks of pregnancy. UDCA treatment significantly reduced serum taurocholic and taurodeoxycholic acid concentrations. Finally, bile acid profiles were similar in normal pregnancy and pregnancy associated with pruritus gravidarum. The study by Tribe et al. (this issue) presents a significant contribution to the solution of this enigmatic disease by expanding our knowledge on the pathophysiology of ICP and proposing a convenient method for diagnosis and monitoring of this disorder.

Original languageEnglish (US)
Pages (from-to)596-598
Number of pages3
JournalAmerican Journal of Gastroenterology
Volume105
Issue number3
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Bile Acids and Salts
Pregnancy
Ursodeoxycholic Acid
Pruritus
Taurodeoxycholic Acid
Cholic Acid
Taurocholic Acid
Liver Function Tests
Taurine
Serum
Glycine
Chromatography
Liver Diseases
Intrahepatic Cholestasis of Pregnancy
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

@article{63aeff3ce1344310a51c050bc91a03f2,
title = "Editorial: Bile acid profiles in intrahepatic cholestasis of pregnancy: Is this the solution to the enigma of intrahepatic cholestasis of pregnancy",
abstract = "Intrahepatic cholestasis of pregnancy (ICP) is a rare pregnancy-related liver disease characterized by pruritus, abnormal liver function tests, and an increased risk of fetal complications. An increase in the levels of bile acids is considered to be the diagnostic hallmark of the disease. Ursodeoxycholic acid (UDCA) is currently the most effective therapy. Tribe et al. (this issue) hypothesized that measuring the longitudinal profiles of individual bile acids would provide further insight into the mechanisms of disease. They used a novel chromatography method, which allowed the simultaneous measurement of 15 serum bile acids between 16 weeks of pregnancy and 4 weeks post-partum. ICP was associated with a predominant rise in cholic acid conjugated with taurine and glycine from 24 weeks of pregnancy. UDCA treatment significantly reduced serum taurocholic and taurodeoxycholic acid concentrations. Finally, bile acid profiles were similar in normal pregnancy and pregnancy associated with pruritus gravidarum. The study by Tribe et al. (this issue) presents a significant contribution to the solution of this enigmatic disease by expanding our knowledge on the pathophysiology of ICP and proposing a convenient method for diagnosis and monitoring of this disorder.",
author = "Emmanouil Sinakos and Keith Lindor",
year = "2010",
doi = "10.1038/ajg.2009.639",
language = "English (US)",
volume = "105",
pages = "596--598",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Editorial

T2 - Bile acid profiles in intrahepatic cholestasis of pregnancy: Is this the solution to the enigma of intrahepatic cholestasis of pregnancy

AU - Sinakos, Emmanouil

AU - Lindor, Keith

PY - 2010

Y1 - 2010

N2 - Intrahepatic cholestasis of pregnancy (ICP) is a rare pregnancy-related liver disease characterized by pruritus, abnormal liver function tests, and an increased risk of fetal complications. An increase in the levels of bile acids is considered to be the diagnostic hallmark of the disease. Ursodeoxycholic acid (UDCA) is currently the most effective therapy. Tribe et al. (this issue) hypothesized that measuring the longitudinal profiles of individual bile acids would provide further insight into the mechanisms of disease. They used a novel chromatography method, which allowed the simultaneous measurement of 15 serum bile acids between 16 weeks of pregnancy and 4 weeks post-partum. ICP was associated with a predominant rise in cholic acid conjugated with taurine and glycine from 24 weeks of pregnancy. UDCA treatment significantly reduced serum taurocholic and taurodeoxycholic acid concentrations. Finally, bile acid profiles were similar in normal pregnancy and pregnancy associated with pruritus gravidarum. The study by Tribe et al. (this issue) presents a significant contribution to the solution of this enigmatic disease by expanding our knowledge on the pathophysiology of ICP and proposing a convenient method for diagnosis and monitoring of this disorder.

AB - Intrahepatic cholestasis of pregnancy (ICP) is a rare pregnancy-related liver disease characterized by pruritus, abnormal liver function tests, and an increased risk of fetal complications. An increase in the levels of bile acids is considered to be the diagnostic hallmark of the disease. Ursodeoxycholic acid (UDCA) is currently the most effective therapy. Tribe et al. (this issue) hypothesized that measuring the longitudinal profiles of individual bile acids would provide further insight into the mechanisms of disease. They used a novel chromatography method, which allowed the simultaneous measurement of 15 serum bile acids between 16 weeks of pregnancy and 4 weeks post-partum. ICP was associated with a predominant rise in cholic acid conjugated with taurine and glycine from 24 weeks of pregnancy. UDCA treatment significantly reduced serum taurocholic and taurodeoxycholic acid concentrations. Finally, bile acid profiles were similar in normal pregnancy and pregnancy associated with pruritus gravidarum. The study by Tribe et al. (this issue) presents a significant contribution to the solution of this enigmatic disease by expanding our knowledge on the pathophysiology of ICP and proposing a convenient method for diagnosis and monitoring of this disorder.

UR - http://www.scopus.com/inward/record.url?scp=77749277164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749277164&partnerID=8YFLogxK

U2 - 10.1038/ajg.2009.639

DO - 10.1038/ajg.2009.639

M3 - Article

C2 - 20203641

AN - SCOPUS:77749277164

VL - 105

SP - 596

EP - 598

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 3

ER -